| [1] |
Armstrong EJ, Saced H, Alvandi B, et al.Nitinol self-expanding stents vs balloon angioplasty for very long femoropopliteal lesions[J]. J Endovasc Ther, 2014, 21(1):34-43.
|
| [2] |
Patel MR, Conte MS, et al.Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium(PARC)[J]. Journal of the American College of Cardiology, 2015, 65(9):931-941.
|
| [3] |
Madhan Shanmugasundaram.Drug-coated balloon in peripheral artery disease[J]. Cardiovasc Revasc Med,2019,20(4):338-343.
|
| [4] |
段润丹,谢辉,吕磊,等.股腘动脉支架断裂与支架内再狭窄相关性分析[J].介入放射学杂志,2017,26(6):496-499.
|
| [5] |
任天才,余朝文. 药物涂层球囊在下肢动脉硬化闭塞症支架内再狭窄治疗中的应用观察[J]. 山东医药, 2021, 61(8): 51-54.
|
| [6] |
Peter A Schneider, John R Laird, et al.Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries[J] Circulation: Cardiovascular Intervertiaons, 2018, 11(1): e5891.
|
| [7] |
Gary M Ansel.Drug-coated balloons versus drug-eluting stents in the femoropopliteal artery: comparing apples to oranges[J].Cardiovasc Surg (Torino),2019,60(4):456-459.
|
| [8] |
Eiji Shibahashi, Kentaro Jujo.Leaving Nothing Is Leaving Unanswered Questions - Drug-Coated Balloon Angioplasty for Femoropopliteal Artery[J].Circ J,2021,85(12):2157-2158.
|
| [9] |
王鹏, 管宇珩, 包晗,等. 国产紫杉醇药涂球囊治疗下肢动脉粥样硬化闭塞症的早期临床疗效评估. 放射学实践,2018,33(12):1322-1325.
|
| [10] |
Gérald Gahide, Samuel C Phaneuf,et al.Paclitaxel and mortality in patients with claudication and de novo femoropopliteal lesions: a historical cohort study[J].CVIR Endovasc,2021,4(1):65.
|
